Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

PHARMARON MANUFACTURING SERVICES (UK) LTD

Company number 05188033

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
07 Jan 2022 TM01 Termination of appointment of Bernard Pluta as a director on 7 January 2022
07 Jan 2022 TM01 Termination of appointment of Mark Royston Quick as a director on 7 January 2022
07 Jan 2022 AP03 Appointment of Mr. Stephen Christopher Lewinton as a secretary on 7 January 2022
07 Jan 2022 AP01 Appointment of Dr. Boliang Lou as a director on 7 January 2022
07 Jan 2022 AP01 Appointment of Mr. Stephen Christopher Lewinton as a director on 7 January 2022
07 Jan 2022 CERTNM Company name changed aesica pharmaceuticals LIMITED\certificate issued on 07/01/22
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2022-01-07
04 Jan 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
21 Dec 2021 SH01 Statement of capital following an allotment of shares on 21 December 2021
  • GBP 672,910.37
10 Nov 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Re: facility agreement/ company business 03/10/2018
10 Nov 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Terms of agreements of the sale and purchase of all the issued capital of the company is approved and any amount of monies for consideration payable to the members of the company are hereby waived for all purposes 27/09/2011
26 Oct 2021 SH03 Purchase of own shares.
19 Oct 2021 MR04 Satisfaction of charge 15 in full
02 Sep 2021 RP04AR01 Second filing of the annual return made up to 6 July 2014
02 Sep 2021 RP04AR01 Second filing of the annual return made up to 6 July 2015
25 Aug 2021 RP04CS01 Second filing of Confirmation Statement dated 6 July 2016
14 Jul 2021 CS01 Confirmation statement made on 14 July 2021 with updates
06 Jul 2021 CS01 Confirmation statement made on 6 July 2021 with no updates
23 Apr 2021 AP01 Appointment of Mr Bernard Pluta as a director on 9 April 2021
22 Apr 2021 TM01 Termination of appointment of Thomas Bengt Eldered as a director on 9 April 2021
08 Mar 2021 MR01 Registration of charge 051880330024, created on 4 March 2021
20 Nov 2020 PSC02 Notification of Consort Medical Limited as a person with significant control on 20 October 2020
18 Nov 2020 PSC05 Change of details for Aesica Bc Limited as a person with significant control on 20 October 2020
03 Nov 2020 PSC07 Cessation of Aesica Bc Limited as a person with significant control on 20 October 2020
01 Oct 2020 AA01 Current accounting period shortened from 31 January 2021 to 31 December 2020
04 Aug 2020 AA Full accounts made up to 31 January 2020